- Working Hour: Monday - Friday | 9:00 am to 5:00 pm
- Email: info@themoonmd.com
Inherited pulmonary diseases encompass a variety of lung disorders that often share overlapping symptoms. These conditions can impact the airways (such as cystic fibrosis and primary ciliary dyskinesia), lung tissue (pulmonary fibrosis, Birt-Hogg-Dubé syndrome, tuberous sclerosis), and pulmonary vasculature. Many of these rare lung diseases appear from birth up to around age 60 and can be serious, chronic, and debilitating. Accurate diagnosis is crucial, as these conditions often require long-term and costly treatments. Using NGS-based genetic testing, healthcare providers can achieve rapid and precise diagnoses, enabling early and personalized interventions.
Genetic testing is a highly effective method for subtyping hereditary pulmonary diseases, providing critical information for personalized treatment and management. For example, variations in the CFTR gene, which cause cystic fibrosis, are specifically targeted. Beyond cystic fibrosis, pinpointing the exact genetic defect in any hereditary lung disease is essential for accurate genetic counseling and risk assessment. Identifying at-risk family members allows for early preventive measures, lifestyle recommendations, and regular medical monitoring. Additionally, genetic diagnostics play an important role in family planning and informed healthcare decisions.
